The drug DRP-104 successfully hindered lung cancer cell growth by blocking glutamine uptake, potentially offering a new approach to combat treatment-resistant tumor cells.
[
add
]
[
|
|
...
]
The drug DRP-104 successfully hindered lung cancer cell growth by blocking glutamine uptake, potentially offering a new approach to combat treatment-resistant tumor cells.